Skip to main content
. 2018 Feb 20;41(5):2517–2526. doi: 10.3892/ijmm.2018.3506

Figure 1.

Figure 1

Mangiferin protects MC3T3-E1 cells against Dex-induced inhibition of viability. (A) MC3T3-E1 cells were treated with Dex at the indicated concentrations for 24, 48 and 72 h. (B) MC3T3-E1 cells were treated with mangiferin at the indicated concentrations for 24, 48 and 72 h. (C) Prior to exposure to 1 µM Dex for 24, 48 and 72 h, MC3T3-E1 cells were pretreated with various concentrations of mangiferin for 3 h. Cell viability was measured by Cell Counting kit-8 assay. ΔP<0.05, ΔΔP<0.01 and ΔΔΔP<0.001 compared with the control group at 24 h; ++P<0.01 and +++P<0.001 compared with the control group at 48 h; *P<0.05, **P<0.01 and ***P<0.001 compared with the control group at 72 h; #P<0.05, ##P<0.01 and ###P<0.001 compared with the Dex treatment group. Dex, dexamethasone.